earnings
confidence high
sentiment positive
materiality 0.75
Clover Health Q1 beat: revenue $462M (+33%), Adj EBITDA $26M (+279%); raises FY guidance
CLOVER HEALTH INVESTMENTS, CORP. /DE
2026-Q1 EPS
reported $0.00
vs consensus $0.03
▼ miss
(-100.0%)
- Q1 total revenue $462M, up 33% YoY; GAAP net loss improved to $1M from $19M loss a year ago.
- Adjusted EBITDA $26M, up 279% YoY; Adjusted Net income $25M, up 322% YoY.
- Medicare Advantage membership 103,418, up 30% YoY; Insurance BER 86.1%.
- Full-year 2025 Adj EBITDA guidance raised to $50M-$70M from $45M-$70M; revenue outlook unchanged.
- CEO cites Clover Assistant's CHF whitepaper showing 18% lower all-cause hospitalizations.